Bronwyn M. Kivell

Wellington, WGN, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Development and Application of an LC-MS Method for the Pharmacokinetics and Pharmacodynamics of Oral Therapeutic Efficacy of Nalfurafine.

Development and Application of an LC-MS Method for the Pharmacokinetics and Pharmacodynamics of Oral Therapeutic Efficacy of Nalfurafine.

Journal: Basic & clinical pharmacology & toxicology

Published: June 16, 2025

Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis.

Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis.

Journal: Clinical & translational immunology

Published: June 04, 2025

Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol.

Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: May 29, 2025

Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.

Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.

Journal: Molecules (Basel, Switzerland)

Published: December 17, 2024

Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin-induced demyelination in mice.

Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin-induced demyelination in mice.

Journal: Glia

Published: November 30, 2023

Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination.

Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination.

Journal: Clinical & translational immunology

Published: May 21, 2023

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

Journal: Molecules (Basel, Switzerland)

Published: May 05, 2023

Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.

Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.

Journal: Brain sciences

Published: October 31, 2022

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Journal: Frontiers in pharmacology

Published: December 16, 2021

Oxidative Metabolism as a Modulator of Kratom's Biological Actions.

Oxidative Metabolism as a Modulator of Kratom's Biological Actions.

Journal: Journal of medicinal chemistry

Published: November 16, 2021

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice.

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice.

Journal: Frontiers in pharmacology

Published: November 11, 2021

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.

The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.

Journal: Pharmacology, biochemistry, and behavior

Published: October 31, 2021

Showing 1-12 of 44

Last Updated: 09/26/2026